» Articles » PMID: 30254851

Association of Serum Mineral Parameters with Mortality in Hemodialysis Patients: Data from the Korean End-stage Renal Disease Registry

Overview
Specialty Nephrology
Date 2018 Sep 27
PMID 30254851
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We investigated the associations between mineral metabolism parameters and mortality to identify optimal targets in Korean hemodialysis patients.

Methods: Among hemodialysis patients registered in the end-stage renal disease registry of the Korean Society of Nephrology between March 2012 and June 2017, those with serum calcium, phosphorus, and intact parathyroid hormone (iPTH) measured at enrollment were included. Association of serum levels of calcium, phosphorus, and iPTH with all-cause mortality was analyzed.

Results: Among 21,433 enrolled patients, 3,135 (14.6%) died during 24.8 ± 14.5 months of follow-up. After multivariable adjustment, patients in the first quintile of corrected calcium were associated with lower mortality (hazard ratio [HR], 0.84; 95% confidence interval [95% CI], 0.71-0.99; = 0.003), while those in the fifth quintile were associated with higher mortality (HR, 1.39; 95% CI, 1.20-1.61; < 0.001) compared with those in the third quintile. For phosphorus, only the lowest quintile was significantly associated with increased mortality (HR, 1.24; 95% CI, 1.08-1.43; = 0.003). The lowest (HR, 1.18; 95% CI, 1.02-1.36; = 0.026) and highest quintiles of iPTH (HR, 1.24; 95% CI, 1.05-1.46; = 0.013) were associated with increased mortality. For target counts achieved according to the Kidney Disease Outcomes Quality Initiative guideline, patients who did not achieve any mineral parameter targets hadhigher mortality than those who achieved all three targets (HR, 1.37; 95% CI, 1.12-1.67; = 0.003).

Conclusion: In Korean hemodialysis patients, high serum calcium, low phosphorus, and high and low iPTH levels were associated with increased all-cause mortality.

Citing Articles

Serum phosphate levels and the development of sepsis associated acute kidney injury: evidence from two independent databases.

Fang Y, Zhang Y, Zhang X Front Med (Lausanne). 2024; 11:1367064.

PMID: 38585149 PMC: 10995237. DOI: 10.3389/fmed.2024.1367064.


Importance of dialysis specialists in early mortality in elderly hemodialysis patients: a multicenter retrospective cohort study.

Park Y, Lee J, Yoon S, Yun S, Kim H, Bae E Sci Rep. 2024; 14(1):1927.

PMID: 38253679 PMC: 10803298. DOI: 10.1038/s41598-024-52170-9.


Alterations in the Mineral Bone Metabolism of Living Kidney Donors After Uni-Nephrectomy: Prospective Observational Study.

Lee H, Eum S, Ko E, Cho H, Yang C, Chung B Front Med (Lausanne). 2021; 8:741944.

PMID: 34722580 PMC: 8554047. DOI: 10.3389/fmed.2021.741944.


Reduction of Secreted Frizzled-Related Protein 5 Drives Vascular Calcification through Wnt3a-Mediated Rho/ROCK/JNK Signaling in Chronic Kidney Disease.

Oh Y, Kim H, Kim A, Ro H, Chang J, Lee H Int J Mol Sci. 2020; 21(10).

PMID: 32429518 PMC: 7278993. DOI: 10.3390/ijms21103539.


Low parathyroid hormone level predicts infection-related mortality in incident dialysis patients: a prospective cohort study.

Hong Y, Kim J, Kim Y, Chang Y, Park C, Kim S Korean J Intern Med. 2019; 35(1):160-170.

PMID: 31648433 PMC: 6960040. DOI: 10.3904/kjim.2018.264.


References
1.
Naylor K, McArthur E, Leslie W, Fraser L, Jamal S, Cadarette S . The three-year incidence of fracture in chronic kidney disease. Kidney Int. 2014; 86(4):810-8. DOI: 10.1038/ki.2013.547. View

2.
Hwang E, Choi B, Oh K, Kwon Y, Kim G . Management of chronic kidney disease-mineral and bone disorder: Korean working group recommendations. Kidney Res Clin Pract. 2015; 34(1):4-12. PMC: 4570602. DOI: 10.1016/j.krcp.2015.02.002. View

3.
. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003; 42(4 Suppl 3):S1-201. View

4.
Faull R . Managing bone parameters in dialysis patients: international guideline conflicts. Semin Dial. 2007; 20(3):191-4. DOI: 10.1111/j.1525-139X.2007.00272.x. View

5.
Cho J, Jang H, Jung H, Choi J, Park S, Kim C . A Real-world Cost-effectiveness Analysis of Sevelamer Versus Calcium Acetate in Korean Dialysis Patients. Clin Ther. 2017; 40(1):123-134. DOI: 10.1016/j.clinthera.2017.02.005. View